Literature DB >> 24797536

Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension.

Teresa Chiva1, Cristina Ripoll, Fernando Sarnago, Diego Rincón, Judith Gómez-Camarero, Evelyn Galindo, María-Vega Catalina, Jaime Elizaga, Rafael Bañares.   

Abstract

BACKGROUND & AIMS: Diagnosis of portopulmonary hypertension (POPH) is based on the presence of portal hypertension and the same haemodynamic criteria as pulmonary arterial hypertension (PAH). However, the typical hyperdynamic circulation of cirrhosis may have some impact on the diagnosis of POPH. The aim was to compare the haemodynamic pattern of the pulmonary circulation between cirrhotics and non-cirrhotics, including patients with PAH. PATIENTS AND METHODS: 600 patients with cirrhosis [male 77.5%, age 54 (47-60) years, Child A: 14.7%, B: 54.3%, C: 31%] received right heart catheterization. For comparison, 118 non-cirrhotic patients [male 60%, age 64 (53-65) years] with right heart catheterization and PCWP <20 mmHg were included. Both were divided into 3 groups, A: absence of pulmonary arterial hypertension; B or intermediate group: MPAP >25 mmHg, PVR 120-240 dyn s cm(-5) and PCWP <15 mmHg (or PCWP >15 mmHg with TPG ≥12 mmHg); C: pulmonary arterial hypertension (same criteria as B except PVR ≥240 dyn s cm(-5) ).
RESULTS: Distribution of patients with cirrhosis was A 583, B 7 and C 10. Prevalence of POPH was 1.7%. Cirrhotics had lower SVR and greater CO than non-cirrhotics (P < 0.05). Interestingly, patients with cirrhosis without PAH (groups A and B) had lower PVR (P < 0.05) when comparing with non-cirrhotics, while no differences in PVR were observed in group C. However, mean TPG was greater in group C of cirrhotics [36.6 mmHg (12.2) vs. 27.1 mmHg (10.1); P = 0.034].
CONCLUSIONS: Patients with cirrhosis have lower PVR. TPG is greater in POPH than PAH. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of POPH.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  liver transplantation; portopulmonary hypertension; pulmonary arterial hypertension; pulmonary vascular resistance; transpulmonary gradient

Mesh:

Year:  2014        PMID: 24797536     DOI: 10.1111/liv.12562

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  3 in total

1.  Prevalence and Clinical Features of Portopulmonary Hypertension in Patients With Hepatic Cirrhosis: An Echocardiographic Study.

Authors:  Anany Gupta; Akshyaya Pradhan; Sanjay Mehrotra; Ravi Misra; Kauser Usman; Ajay Kumar; Shivani Pandey
Journal:  Cureus       Date:  2022-05-13

Review 2.  Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.

Authors:  Lynn A Fussner; Michael J Krowka
Journal:  Curr Gastroenterol Rep       Date:  2016-06

3.  The effects of terlipressin and direct portacaval shunting on liver hemodynamics following 80% hepatectomy in the pig.

Authors:  John S Hammond; Fred Godtliebsen; Sonja Steigen; I Neil Guha; Judy Wyatt; Arthur Revhaug; Dileep N Lobo; Kim E Mortensen
Journal:  Clin Sci (Lond)       Date:  2019-01-15       Impact factor: 6.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.